Artisan Partners Limited Partnership Takes $148.98 Million Position in Astera Labs, Inc. $ALAB

Artisan Partners Limited Partnership purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 895,530 shares of the company’s stock, valued at approximately $148,980,000.

A number of other institutional investors have also made changes to their positions in the business. Lido Advisors LLC raised its holdings in shares of Astera Labs by 0.5% in the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after buying an additional 57 shares during the last quarter. Perigon Wealth Management LLC raised its holdings in shares of Astera Labs by 6.2% in the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after buying an additional 73 shares during the last quarter. Clearstead Advisors LLC raised its holdings in shares of Astera Labs by 13.6% in the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock valued at $125,000 after buying an additional 76 shares during the last quarter. Sound Income Strategies LLC raised its holdings in shares of Astera Labs by 9.2% in the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock valued at $164,000 after buying an additional 76 shares during the last quarter. Finally, Venturi Wealth Management LLC raised its holdings in shares of Astera Labs by 2.6% in the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after buying an additional 84 shares during the last quarter. 60.47% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts have weighed in on the company. Evercore reissued an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. Barclays boosted their price objective on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Morgan Stanley boosted their price objective on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. TD Cowen boosted their price objective on Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a report on Wednesday, May 6th. Finally, Roth Mkm reissued a “buy” rating and set a $275.00 price objective on shares of Astera Labs in a report on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Stock Performance

NASDAQ ALAB opened at $361.71 on Wednesday. The business has a 50 day simple moving average of $247.50 and a 200 day simple moving average of $182.34. Astera Labs, Inc. has a 52-week low of $84.78 and a 52-week high of $398.13. The stock has a market cap of $62.00 billion, a price-to-earnings ratio of 244.40, a PEG ratio of 5.15 and a beta of 3.94.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business’s quarterly revenue was up 93.5% on a year-over-year basis. During the same period last year, the company posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Activity at Astera Labs

In related news, CEO Jitendra Mohan sold 28,737 shares of the stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $249.62, for a total value of $7,173,329.94. Following the sale, the chief executive officer owned 3,789,232 shares in the company, valued at approximately $945,868,091.84. This represents a 0.75% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of the stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $291.03, for a total value of $231,659.88. Following the completion of the sale, the general counsel owned 103,343 shares in the company, valued at approximately $30,075,913.29. This trade represents a 0.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 2,161,256 shares of company stock worth $459,844,296. Insiders own 10.40% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.